PT728015E - Antigenes polipeptidicos combinatoriais - Google Patents

Antigenes polipeptidicos combinatoriais

Info

Publication number
PT728015E
PT728015E PT93916641T PT93916641T PT728015E PT 728015 E PT728015 E PT 728015E PT 93916641 T PT93916641 T PT 93916641T PT 93916641 T PT93916641 T PT 93916641T PT 728015 E PT728015 E PT 728015E
Authority
PT
Portugal
Prior art keywords
combinatorial
antigens
variants
polypeptidic
protein
Prior art date
Application number
PT93916641T
Other languages
English (en)
Inventor
Roberto Crea
Original Assignee
Creagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creagen Inc filed Critical Creagen Inc
Publication of PT728015E publication Critical patent/PT728015E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT93916641T 1992-06-18 1993-06-18 Antigenes polipeptidicos combinatoriais PT728015E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90012392A 1992-06-18 1992-06-18

Publications (1)

Publication Number Publication Date
PT728015E true PT728015E (pt) 2006-07-31

Family

ID=25412008

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93916641T PT728015E (pt) 1992-06-18 1993-06-18 Antigenes polipeptidicos combinatoriais

Country Status (10)

Country Link
US (1) US6432675B1 (pt)
EP (1) EP0728015B1 (pt)
JP (2) JP3764476B2 (pt)
AT (1) ATE319738T1 (pt)
AU (1) AU678371B2 (pt)
DE (1) DE69333992T2 (pt)
DK (1) DK0728015T3 (pt)
ES (1) ES2260754T3 (pt)
PT (1) PT728015E (pt)
WO (1) WO1994000151A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
JP4391827B2 (ja) * 2002-02-08 2009-12-24 バリエーション バイオテクノロジーズ インコーポレイティド 可変性ペプチドエピトープの免疫原性製剤及びその製造方法
DE60316547T2 (de) * 2002-04-17 2008-07-03 Bioren, Inc., San Carlos Doping bei der walk-through-mutagenese
RU2237065C2 (ru) * 2002-10-03 2004-09-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека
US8044185B2 (en) * 2005-09-06 2011-10-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
US20090169576A1 (en) * 2005-10-26 2009-07-02 Roberto Crea Influenza combinatorial antigen vaccine
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
JP5247009B2 (ja) * 2006-06-16 2013-07-24 独立行政法人理化学研究所 配列抽出装置、配列抽出方法、プログラムおよび記録媒体
US20100093601A1 (en) * 2008-05-19 2010-04-15 Brett Tyler Compositions and methods to protect cells by blocking entry of pathogen proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0525828A3 (en) 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
EP0311228A3 (en) 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
AU4308689A (en) 1988-09-02 1990-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
AU640619B2 (en) 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
PT94276A (pt) 1989-06-05 1991-02-08 Anticorpo monoclonal capaz de neutralizar o prototipo mn de hiv
WO1991006575A1 (en) 1989-11-03 1991-05-16 Repligen Corporation Hiv-1 specific human monoclonal antibody
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method

Also Published As

Publication number Publication date
WO1994000151A1 (en) 1994-01-06
DE69333992T2 (de) 2006-11-30
DE69333992D1 (de) 2006-05-04
AU4642893A (en) 1994-01-24
JPH07508520A (ja) 1995-09-21
JP3764476B2 (ja) 2006-04-05
EP0728015A4 (en) 1997-01-29
EP0728015B1 (en) 2006-03-08
ES2260754T3 (es) 2006-11-01
US6432675B1 (en) 2002-08-13
JP2004121266A (ja) 2004-04-22
AU678371B2 (en) 1997-05-29
DK0728015T3 (da) 2006-07-17
EP0728015A1 (en) 1996-08-28
ATE319738T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DE69434475D1 (de) Impfstoff gegen prostatakrebs
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
NO994983L (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
NO973250L (no) Preparater for avlevering av antigener
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
MX9704897A (es) Secuencias del anticuerpo anti-idiotipo monoclonal recombinante 3h1 relacionadas con el antigeno carcinoembrionico humano.
DK0885244T3 (da) Peptidimmunogener til vaccination imod og til behandling af allergi
NO166303C (no) Fremgangsmaate ved kvantitativ bestemmelse av protein c ogaktivatorpreparat til gjennomfoering av fremgangsmaaten.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
PT728015E (pt) Antigenes polipeptidicos combinatoriais
ATE101876T1 (de) Verfahren zur verringerung der heterogenitaet von monoklonalen antikoerpern.
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
ES8606411A1 (es) Procedimiento para la determinacion de fibrina
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
ATE230024T1 (de) Entwicklung von dns-sonden und immunologischen reagenzien von menschlichen tumor-assoziierten antigenen
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
DE69025761D1 (de) Verfahren zur erhöhung der rate der modifikation metastabiler bindungen
ATE12986T1 (de) Verfahren zur bestimmung von carcinoembryonalem antigen (cea) und zur bestimmung geeignete antikoerperloesung.
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
DK630886A (da) Monoklonalt antistof mod human pancreas-amylase, fremgangsmaade til fremstilling deraf og fremgangsmaade til bestemmelse af human pancreas-amylase ved hjaelp af antistoffet
ATE80554T1 (de) Verfahren zur passiven immunisierung von saeugetieren mittels gefluegel- und/oder rinderantik¯rper und zusammensetzungen zu diesem zweck.
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.